PubRank

Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) (RCT-IVVE)

Clinical Trial ID NCT02762851

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02762851

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 47.90
2 Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 21.49
3 Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010 16.40
4 Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012 10.09
5 Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008 9.62
6 Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010 8.17
7 Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011 8.14
8 Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012 6.60
9 n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012 6.16
10 Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010 6.05
11 Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003 3.49
12 Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009 2.97
13 Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999 2.75
14 Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013 2.62
15 Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011 2.60
16 Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2012 2.40
17 Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002 1.81
18 National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008 1.63
19 Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol 2007 1.58
20 Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 2010 1.58
21 The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 2010 1.50
22 Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000 1.29
23 Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection 2009 1.29
24 Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 2013 1.21
25 Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 2004 1.19
26 The composition of coronary-artery plaques. N Engl J Med 1997 1.15
27 Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997 1.13
28 Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000 1.06
29 Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002 1.06
30 Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997 1.05
31 Impact of influenza vaccination on major cause-specific mortality. Vaccine 2006 1.04
32 Influenza vaccines for preventing coronary heart disease. Cochrane Database Syst Rev 2008 1.02
33 Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006 0.99
34 Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 2001 0.97
35 Influenza vaccination and major adverse vascular events in high-risk patients. Circulation 2012 0.86
36 Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary prevention. Eur Heart J 2011 0.83
37 Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis. J Infect Dis 2000 0.80
38 Vascular events responsible for thrombotic occlusion of a blood vessel. Clin Cardiol 1993 0.75
Next 100